1. Home
  2. GNTA vs KUKE Comparison

GNTA vs KUKE Comparison

Compare GNTA & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTA
  • KUKE
  • Stock Information
  • Founded
  • GNTA 2014
  • KUKE 2002
  • Country
  • GNTA Italy
  • KUKE China
  • Employees
  • GNTA N/A
  • KUKE N/A
  • Industry
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • KUKE Other Consumer Services
  • Sector
  • GNTA Health Care
  • KUKE Real Estate
  • Exchange
  • GNTA Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • GNTA 67.4M
  • KUKE 49.8M
  • IPO Year
  • GNTA 2021
  • KUKE 2021
  • Fundamental
  • Price
  • GNTA $5.34
  • KUKE $0.90
  • Analyst Decision
  • GNTA Strong Buy
  • KUKE
  • Analyst Count
  • GNTA 1
  • KUKE 0
  • Target Price
  • GNTA $25.00
  • KUKE N/A
  • AVG Volume (30 Days)
  • GNTA 28.4K
  • KUKE 834.1K
  • Earning Date
  • GNTA 01-01-0001
  • KUKE 11-05-2024
  • Dividend Yield
  • GNTA N/A
  • KUKE N/A
  • EPS Growth
  • GNTA N/A
  • KUKE N/A
  • EPS
  • GNTA N/A
  • KUKE N/A
  • Revenue
  • GNTA N/A
  • KUKE $14,784,158.00
  • Revenue This Year
  • GNTA N/A
  • KUKE N/A
  • Revenue Next Year
  • GNTA N/A
  • KUKE N/A
  • P/E Ratio
  • GNTA N/A
  • KUKE N/A
  • Revenue Growth
  • GNTA N/A
  • KUKE N/A
  • 52 Week Low
  • GNTA $2.20
  • KUKE $0.47
  • 52 Week High
  • GNTA $7.28
  • KUKE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • GNTA 56.89
  • KUKE 56.06
  • Support Level
  • GNTA $4.89
  • KUKE $0.47
  • Resistance Level
  • GNTA $6.20
  • KUKE $1.00
  • Average True Range (ATR)
  • GNTA 0.70
  • KUKE 0.16
  • MACD
  • GNTA -0.06
  • KUKE 0.03
  • Stochastic Oscillator
  • GNTA 37.32
  • KUKE 84.92

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: